Clinical Characteristics of DKA in Patients with COVID-19 Infection: A Case Series | Asian Journal o

Background: Diabetes mellitus (DM) is one of the co-morbidities that might raise COVID-19 patients' death risk. There hasn't been enough research done on the features of people with diabetic ketoacidosis (DKA) and COVID-19 co-morbidity.

The goal of this study was to look at the characteristics of DKA and how it affected individuals with COVID19 infection.

Methods: In this study, we describe seven patients who were hospitalised to our department with DKA and COVID-19. The test results, imaging, and outcomes of each patient were meticulously documented.

The average initial random blood sugar and serum HCO3 among the patients in this survey were 463.71mg/dl and 9.47mmol/L, respectively. The bulk of the patients (71 percent) had DKA symptoms rather than COVID-19-related respiratory symptoms. In this case, four patients died survey. All four patients who died had significant DKA, with one having mild lung involvement, one having moderate, and two having severe lung involvement. The average C-reactive protein (CRP) and Lactate dehydrogenase (LDH) levels in the patients who died were >150 mg/dl and 813 U/L, respectively.

Conclusion: In COVID-19 co morbidity, DKA is a frequent manifestation after an infectious origin. It can manifest itself in a variety of ways, with a variety of symptoms and effects. More advanced research with a bigger sample size are needed to explore comprehensive DKA features, management, and results in order to change the DKA management regimen in COVID-19 infection, we believe.

Please see the link :- https://globalpresshub.com/index.php/AJMCR/article/view/1317